Dimensional Fund Advisors LP Eye Point Pharmaceuticals, Inc. Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 69,962 shares of EYPT stock, worth $949,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,962
Previous 22,717
207.97%
Holding current value
$949,384
Previous $123,000
434.96%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EYPT
# of Institutions
160Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$113 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$92.3 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$92.3 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$62.4 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$58.4 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $462M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...